Omalizumab: A novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis?

Clinical and Experimental Rheumatology

Volumn 31, Issue SUPPL.75, 2013, Pages

  Latorre, M ^a   Tani, C ^a   Baldini, C ^a   Talarico, R ^a   Seccia, V ^a   Mosca, M ^a   Notarstefano, C ^a   Paggiaro, P L ^a   Rossa, A Della ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LONG ACTING DRUG; METHOTREXATE; OMALIZUMAB; STEROID;

ADULT; ASTHMA; CASE REPORT; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; EOSINOPHIL; HUMAN; LETTER; PRIORITY JOURNAL;

ADULT; ANTI-ASTHMATIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; ASTHMA; CHURG-STRAUSS SYNDROME; DRUG SUBSTITUTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; REMISSION INDUCTION; STEROIDS; TREATMENT OUTCOME;

EID: 84878415741     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (21)

1. DUNOGUE B, PAGNOUX C, GUILLEVIN L: Churg-Strauss syndrome: Clinical symptoms, complementary investigations, prognosis and outcome, and treatment. Semin Respir Crit Care Med 2011; 32: 298-309.
2. TALARICO R, BALDINI C, DELLA ROSSA A et al.: Large-and small-vessel vasculitis: A critical digest of the 2010-2011 literature. Clin Exp Rheumatol 2012; 30: S130-8.
3. BALDINI C, TALARICO R, DELLA ROSSA A, BOMBARDIERI S: Clinical manifestations and treatment of Churg-Strauss syndrome. Rheum Dis Clin North Am 2010; 36: 527-43.
4. PAGNOUX C: Churg-Strauss syndrome: Evolving concepts. Discov Med 2010; 9: 243-52.
5. MOSCA M, TANI C, CARLI L, BOMBARDIERI S: Glucocorticoids in systemic lupus erythematosus. Clin Exp Rheumatol 2011; 29: S126-9.
6. GOVONI M., BOMBARDIERI S, BORTOLUZZI A et al.: Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: Does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology (Oxford) 2012; 51: 157-68.
7. AYRES JG, HIGGINS B, CHILVERS ER, AYRE G, BLOGG M, FOX H: Efficacy and tolerability of antiimmunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma. Allergy 2004; 59: 701-8.
8. BUHL R.,HANF G, SOLER M et al.: The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma. Eur Respir J 2002; 20: 1088-94.
9. BUHL R, SOLER M, MATZ J et al.: Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma. Eur Respir J 2002; 20: 73-8.
10. FINN A, GROSS G, VAN BAVEL J et al.: Omalizumab improves asthma-related quality of life in patients with severe allergic asthma. J Allergy Clin Immunol 2003; 111: 278-84.
11. CAZZOLA M, CAMICIOTTOLI G, BONAVIA M et al.: Italian real-life experience of omalizumab. Respir Med 2010; 104: 1410-6.
12. GIAVINA-BIANCHI P, GIAVINA-BIANCHI M, AGONDI R, KALIL J: Three months' administration of anti-IgE to a patient with Churg-Strauss syndrome. J Allergy Clin Immunol 2007; 119: 1279; author reply -80.
13. GIAVINA-BIANCHI P, GIAVINA-BIANCHI M, AGONDI RC, KALIL J: Anti-IgE in Churg-Strauss syndrome. Thorax 2009; 64: 272; author reply -3.
14. PABST S, TIYERILI V, GROHE C: Apparent response to anti-IgE therapy in two patients with refractory "forme fruste" of Churg-Strauss syndrome. Thorax 2008; 63: 747-8.
15. PUECHAL X, RIVEREAU P, VINCHON F: Churg-Strauss syndrome associated with omalizumab. Eur J Intern Med 2008; 19: 364-6.
16. BARGAGLI E, MADIONI C, OLIVIERI C, PENZA F, ROTTOLI P: Churg-Strauss vasculitis in a patient treated with omalizumab. J Asthma 2008; 45: 115-6.
17. RUPPERT AM, AVEROUS G, STANCIU D et al.: Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment. J Allergy Clin Immunol 2008; 121: 253-4.
18. SPINA MF.,MIADONNA A: Role of omalizumab and steroids in Churg-Strauss syndrome. J Allergy Clin Immunol 2009; 124: 600-1.
19. MASI AT, HUNDER GG, LIE JT et al.: The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-100.
20. GIAVINA-BIANCHI P, GIAVINA-BIANCHI M, AGONDI R, KALIL J: Administration of anti-IgE to a Churg-Strauss syndrome patient. Int Arch Allergy Immunol 2007; 144: 155-8.
21. TRIESTE L, PALLA I, BALDINI C, TALARICO R, D'ANGIOLELLA L, MOSCA M, TURCHETTI G: Systematic vasculitis: how little we know about their societal and economic burden. Clin Exp Rheumatol 2012; 30 (Suppl. 73): S154-S156.